64.20p
+0.31%
Close of 9 Nov 2026, in pence
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Dr Martens
Its shares trade on LSE under the ticker DOCS.L. It has been listed since 29 January 2021. In the fiscal year to 31 March 2026, it reported revenue of £764.9m and net income of £23.8m. At that date it held total assets of £877.3m and shareholders' equity of £361.5m.
Dr. Martens Plc engages in the manufacture and sale of footwear products. The firm operates through three reporting segments: Europe, the Middle East and Africa (EMEA); Americas; and Americas and Asia-Pacific (APAC). Its product categories include Originals, Fusion, Kids, Casual and Accessories. The Originals category comprises boots, shoes and loafers and also included within the Originals category is the Made in England range. The Fusion category comprises platform boots and shoes, sandals, heels, and refined take downs of the Originals. Within the Kids category is the mini-me range, which includes Originals, Fusion, and Casual collections. The company offers various accessories, such as shoe care, laces and socks, leather bags and small leather items. The firm operates in over 60 countries globally, through a range of modes: directly operated stores and ecommerce sites, wholesale partners and distributors.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Consumer Discretionary
- Industry
- Textiles, Apparel & Luxury Goods
- Listed since
- 29 Jan 2021
- Employees
- 2,591
- Website
- drmartensplc.com ↗
Leadership
Pay as last reported
- Mr. Paul MasonNon-Executive Chairman of the Board, since 2015£342,000
- Mr. Ije NwokorieChief Executive Officer, Executive Director, since 2021£303,000
- Mr. Giles WilsonChief Financial Officer, Executive Director, since 2024£1.7m
- Mr. Derek ChanPresident, APAC
- Mr. Mike StopforthPresident, EMEA
- Mr. Geert PeetersChief Operating Officer
- Ms. Bridget JolliffeChief People Officer
- Mr. Graham CalderChief Technology Officer
- Mr. Adam MeekChief Product Officer
- Mr. Erik ZambonStrategy Director
- Ms. Katherine BellauCompany Secretary
- Ms. Tara AlhadeffNon-Independent Non-Executive Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 51
- Environment
- 53
- Social
- 60
- Governance
- 40
- Direct emissions (scope 1)
- 750 t
- Energy emissions (scope 2)
- 2,911 t
- Value chain emissions (scope 3)
- 92 t
- Women in the workforce
- 63%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Dr Martens PLC operates in over 60 countries globally with direct stores and ecommerce platforms.
- The Originals category includes Made in England boots and shoes, enhancing brand prestige.
- The company's product segments cover Originals, Fusion, Kids, Casual, and Accessories globally.
Weaknesses
- The company has 2591 employees, which may limit scalability in global markets.
- Dr Martens PLC's business segments are split into EMEA, Americas, and APAC, causing operational complexity.
- The firm relies on wholesale partners and distributors, increasing dependency on third parties.
Opportunities
- The Americas and APAC segments offer growth potential in emerging markets.
- The Fusion category's platform boots and refined Originals can attract new customer segments.
- The Kids category's mini-me range expands family-oriented product offerings globally.
Threats
- The Textiles, Apparel & Luxury Goods sector faces intense competition from global brands.
- Consumer Discretionary sector volatility may affect discretionary spending on footwear.
- The company's reliance on EMEA, Americas, and APAC segments exposes it to regional economic risks.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.